宣武医院品牌怎么样 申请店铺

我要投票 宣武医院在男科医院行业中的票数:632 更新时间:2026-03-16
宣武医院是哪个国家的品牌?「宣武医院」是 首都医科大学宣武医院 旗下著名品牌。该品牌发源于北京市,由创始人张建在1958年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力宣武医院品牌出海!将品牌入驻外推网,定制宣武医院品牌推广信息,可以显著提高宣武医院产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

宣武医院怎么样

首都医科大学宣武医院创建于1958年,是一所以神经科学和老年医学为重点,以治疗心脑血管疾患为主要特色,承担着医疗、教育、科研、预防、保健和康复任务的大型三级甲等综合医院。

医院在以医院综合实力为主体,神经科学和老年医学为特色的“一体两翼”发展格局下,各学科稳步发展。神经科学各分支学科不断发展壮大。

设立在本院的北京市老年病医疗研究中心和北京市老年保健及疾病防治中心,担负着北京市老年健康服务体系的龙头和执行管理职能使命。已构建成为集管理、服务、医疗、科研、教育等功能为一体的、在国内具特色的老年医学体系,成为对内起示范作用、对外是交流窗口的老年医学研究的重要基地和特色品牌。围绕老年重大慢性疾病防控、老年共病防治及老年综合健康评估等关键问题,整合全国资源,开展基础及临床应用研究,促进生物医药前沿技术向临床防治的转化和推广,提升我国老年人的总体健康水平。

医院占地面积7.6万平方米,总建筑面积9.9万平方米,正在扩建面积8万平方米,开放床位1159张,扩建后将增加480张,年门急诊量达290余万人次,年出院病人5万余人次。

医院拥有高级专业技术人员460余名,包括中科院院士、长江学者和享有政府特贴的突出贡献专家。设有31个中西医临床科室、11个医技科室。拥有脑磁图、西门子双源CT(Force)、西门子双源CT(Flash)、GE宝石能谱CT、PET-CT、SPECT-CT、3.0 T磁共振成像系统、移动式术中放疗系统、双C臂数字减影血管造影机等精密诊疗与科研设备,以及设施完善的数字手术室和杂交手术室。

 “十二五”期间,共获得科研立项467项,其中省部级课题116项,局级课题181项。获批经费32724.11万元。全院共发表国内统计源文章3902篇,SCI文章788篇,临床科研的投入和产出稳步增加。

医院是教育部国家生命科学与人才培养基地-首都医科大学神经病学系、普通外科学系、皮肤与性病学系、老年医学系和首都医科大学神经外科学院二系的系主任单位,拥有博士点20个,硕士点16个。

医院同世界卫生组织、联合国人口基金组织以及美国、德国、日本、意大利、澳大利亚、英国、法国、荷兰、加拿大、瑞典、瑞士、韩国、奥地利等国家的医学研究机构开展广泛的交流与合作。


Xuanwu Hospital, Capital Medical University, was founded in 1958. It is a large three-level A-level general hospital with neuroscience and geriatrics as the focus, and with the treatment of cardiovascular and cerebrovascular diseases as the main feature, which undertakes the tasks of medical treatment, education, scientific research, prevention, health care and rehabilitation. Under the development pattern of "one body and two wings" with comprehensive strength as the main body and neuroscience and geriatrics as the characteristics, all disciplines have developed steadily. The branches of neuroscience have been growing. Beijing geriatric medical research center and Beijing geriatric health care and disease prevention and control center, established in our hospital, are responsible for the leading and executive management functions of Beijing geriatric health service system. It has been built into a featured geriatric medical system with functions of management, service, medical treatment, scientific research and education in China, and has become an important base and characteristic brand of geriatric medical research that plays an exemplary role at home and serves as a communication window at abroad. Focusing on key issues such as prevention and control of major chronic diseases of the elderly, prevention and control of common diseases of the elderly and comprehensive health assessment of the elderly, we will integrate national resources, carry out basic and clinical application research, promote the transformation and promotion of biomedical cutting-edge technology to clinical prevention and control, and improve the overall health level of the elderly in China. The hospital covers an area of 76000 square meters, with a total construction area of 99000 square meters. It is expanding an area of 80000 square meters, with 1159 open beds. After the expansion, it will increase by 480. The annual number of outpatient and emergency patients will reach more than 2.9 million, and the annual number of discharged patients will be more than 50000. The hospital has more than 460 senior professional and technical personnel, including academicians of the Chinese Academy of Sciences, Changjiang Scholars and experts with outstanding contributions enjoying special government posts. There are 31 clinical departments of traditional Chinese and Western medicine and 11 medical technology departments. It has precise diagnosis, treatment and scientific research equipment such as magnetoencephalogram, Siemens dual source CT (force), Siemens dual source CT (flash), Ge gemstone energy spectrum CT, PET-CT, SPECT-CT, 3.0T magnetic resonance imaging system, mobile intraoperative radiotherapy system, double C-arm digital subtraction angiography machine, as well as perfect digital operating room and hybrid operating room. During the 12th Five Year Plan period, 467 scientific research projects were approved, including 116 provincial and ministerial level projects and 181 bureau level projects. The approved fund is 327241100 yuan. The hospital published 3902 articles of domestic statistical source and 788 articles of SCI, and the input and output of clinical research increased steadily. The hospital is the national life science and talent training base of the Ministry of Education - Department of Neurology, Department of general surgery, Department of Dermatology and Venereology, Department of geriatrics and Department of Neurosurgery of Capital Medical University. It has 20 doctoral programs and 16 master programs. The hospital has conducted extensive exchanges and cooperation with the World Health Organization, the United Nations Population Fund and medical research institutions in the United States, Germany, Japan, Italy, Australia, the United Kingdom, France, the Netherlands, Canada, Sweden, Switzerland, South Korea, Austria and other countries.

本文链接: https://brand.waitui.com/ecb326e48.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

中长期资金去年底持有沪市ETF共1.5万亿元

上海证券交易所创新产品部相关负责人近日在参加公开活动时表示,ETF已成为居民财富配置、中长期资金入市的重要载体。截至2025年底,中长期资金持有沪市ETF共1.5万亿元,年内增幅达70%,贡献了超四成的沪市ETF规模增量,其中保险持仓规模增长35%。(e公司)

2小时前

兆驰股份:针对MicroLED在光通信等扩展领域的应用 目前处于样品验证测试阶段

兆驰股份(002429.SZ)发布异动公告,公司注意到市场对MicroLED相关概念关注度较高。公司主营业务未发生改变,针对MicroLED在光通信等扩展领域的应用,目前处于样品验证测试阶段,短期内不会对公司经营业绩产生实质性影响。作为公司战略性新兴业务,激光芯片项目及高速光模块项目目前正处于稳步推进的投产初期阶段,产能爬坡及市场拓展需一定周期。公司光通信业务2025年上半年实现营业收入3.09亿元,占公司同期营业总收入84.83亿元的比例不足5%,业务规模占比较小。(财联社)

2小时前

艾迪药业:多替拉韦钠片获得药品注册批准

艾迪药业3月15日公告,公司近日收到国家药品监督管理局核准签发的多替拉韦钠片《药品注册证书》。该药品为化学药品4类,规格为50mg(以 C20 H19 F2 N3 O5 计),批准的适应症为联合其它抗逆转录病毒药物,用于治疗人类免疫缺陷病毒(HIV)感染的成人和年满12岁的儿童患者。(界面)

2小时前

食材以次充好 多地“刘文祥麻辣烫”门店被查

“刘文祥鸭肉当猪肉牛肉卖”的相关话题冲上热搜。有媒体调查后发现,多家刘文祥门店存在食材以次充好、标注混乱等问题。据了解,福建厦门一家刘文祥门店的肥牛卷,在外卖平台标注为肥牛/牛肉,店员也宣称是牛肉,实则产品包装袋显示为鸭肉。福建漳州一家门店同样存在违规情况。3月14日晚,福建多地市场监管部门展开行动,突击检查刘文祥门店。目前,部分涉事门店已被要求立即整改。市场监管部门表示,将对以假冒真、虚假宣传的行为依法从严查处,并对辖区内所有连锁门店进行拉网式排查。(央视新闻)

2小时前

2026GDC在美国举办,AI相关议题分享超过100场

36氪获悉,2026年游戏开发者大会(简称“GDC”)在美国旧金山举行。官方数据显示,为期5天的大会,有3万余名从业者到场参与,现场举办超700场议题分享与活动。其中,AI相关议题分享超过100场,较2025年增长超110%。本届大会吸引全球400多家科技及游戏厂商参与,腾讯、谷歌、苹果、英伟达、Meta、索尼、微软等亮相。今年,9家中国厂商共计带来27场AI相关议题分享,其中腾讯游戏达21场。

2小时前

本页详细列出关于宣武医院的品牌信息,含品牌所属公司介绍,宣武医院所处行业的品牌地位及优势。
咨询